Company Number: 15348694

Analysis Date: 2025-07-20 14:57 UTC

Financial Health Assessment for MIDX LTD

---

1. Financial Health Score: B

Explanation:
MIDX LTD shows a solid foundation for a newly incorporated company (incorporated December 2023). The company has positive net current assets and shareholders’ funds, indicating initial financial stability. However, the presence of significant convertible loan notes (long-term debt) and modest net assets relative to liabilities suggests some financial leverage and risk, typical for an early-stage research enterprise. Thus, a "B" grade reflects generally good financial health with manageable risks that require monitoring.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	1,867	Low capital investment typical for early-stage research entities.
Current Assets	101,072	Healthy short-term asset base, including cash and debtors.
Cash at Bank	63,428	Good cash reserve, indicating healthy liquidity ("healthy cash flow").
Debtors	37,644	Significant amount owed to the company, potential cash inflow.
Current Liabilities	18,954	Short-term obligations are moderate; comfortably covered by current assets.
Net Current Assets	82,118	Positive working capital, a sign of liquidity strength.
Long-term Liabilities	73,792	Convertible loan notes to University of Nottingham; represents financial leverage.
Net Assets (Equity)	10,193	Positive but modest shareholders' funds; equity cushion present.

Other Vital Observations:

• The company is exempt from audit under small companies rules, reflecting its micro/small status.
• Directors have confirmed no material uncertainties for going concern status.
• Convertible loan notes include rolled-up interest, adding to long-term liability burden.
• The company is in an early development phase with a research focus (SIC 72190).

---

3. Diagnosis: What the Numbers Reveal

MIDX LTD is in the early stages of its lifecycle, with strong liquidity and positive net current assets indicating a "healthy cash flow" symptom. This suggests that the company currently generates or receives sufficient cash inflows to meet its short-term obligations comfortably. The relatively small fixed asset base aligns with its research and experimental development activities, which typically require less tangible capital investment initially.

However, the presence of substantial convertible loan notes (long-term debt) signifies underlying financial leverage. This can be viewed as a "symptom of financial strain" but is a common feature in startup or research-intensive companies reliant on investor funding or institutional loans. The company’s equity base is modest, reflecting its new establishment and initial capitalization.

The directors’ assessment that no going concern issues exist is reassuring, indicating no immediate risk of insolvency. The company benefits from a strong backing by an institutional investor (University of Nottingham), which is also a significant shareholder and creditor, providing strategic support.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

• Monitor Debt Servicing and Fundraising: The convertible loan notes carry interest at 3% above the Bank of England base rate and are repayable upon a successful fundraising round exceeding £2.5 million or after 5 years. The company should prioritize successful fundraising efforts to refinance or repay this debt and avoid heavy interest burdens ("mitigating symptoms of distress").

• Strengthen Equity Base: Consider additional equity injections or grants to build shareholders' funds, which will improve the company’s financial "immune system," reducing reliance on debt and increasing resilience.

• Optimize Working Capital Management: Maintain strong control over debtors to ensure timely collections, preserving healthy cash flow and avoiding liquidity crunches.

• Strategic Cost Management: Continue prudent expense management, especially given the company’s research focus and limited tangible assets, to conserve cash and extend operational runway.

• Prepare for Growth: Develop financial projections and scenario plans anticipating future capital needs and operational scaling, enabling proactive financial management.

---